Pravin Anand moderated a panel discussion on “Commercializing Innovation: the Role of IP, Clinical Trial Legislation, and Bayh-Dole “like” Legislation in Building the Innovative Biopharmaceutical Industry” on January 14th at the US India Business Council (USIBC) Event hosted in New Delhi.
CAUTION NOTICE TO WHOMSOEVER IT MAY CONCERN
This caution notice is being addressed on behalf of the law firm Anand and Anand, having its registered office at B - 41, Nizamuddin East, New Delhi 110 013, India.
The general public is hereby cautioned that certain unknown individuals and agencies have been trying to mislead the public by issuing legal notices and other statement/correspondence
unauthorisedly using our identity ANAND AND ANAND, PRAVIN ANAND, 
etc. whilst wrongfully claiming to be part of our firm and making false claims and allegations.
Please be advised that any person willingly corresponding with such individuals and agencies in any manner whatsoever will be doing so at their own risk, as to costs and consequences. We strongly recommend that no one should respond to such solicitations, and we will not accept any liability whatsoever for any loss that the general public may incur owing to transactions made with such unknown individuals and agencies making false claims.
In case you come across any such fraudulent activity, you may kindly contact our Chief Information Officer Mr. Subroto Panda at subroto@anandandanand.com so that appropriate action may be taken.
Anand and Anand
B-41, Nizamuddin East, New Delhi - 110013